SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/11/22 Accolade, Inc. 10-Q 11/30/21 68:9.1M Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 1.52M 2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 24K 10: R1 Document and Entity Information HTML 77K 11: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 110K 12: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 29K (Parenthetical) 13: R4 Condensed Consolidated Statements of Operations HTML 85K (Unaudited) 14: R5 Condensed Consolidated Statements of Convertible HTML 134K Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) 15: R6 Condensed Consolidated Statements of Convertible HTML 22K Preferred Stock and Stockholders' Deficit (Unaudited) (Parenthetical) 16: R7 Condensed Consolidated Statements of Cash Flows HTML 127K (Unaudited) 17: R8 Background HTML 23K 18: R9 Basis of Presentation and Summary of Significant HTML 67K Accounting Policies 19: R10 Revenue HTML 44K 20: R11 Acquisitions HTML 130K 21: R12 Goodwill and Intangible Assets HTML 57K 22: R13 Fair Value Measurements HTML 74K 23: R14 Debt HTML 45K 24: R15 Equity-based Compensation HTML 122K 25: R16 Income Taxes HTML 27K 26: R17 Net Loss Per Share Attributable to Common HTML 100K Stockholders 27: R18 Commitments and Contingencies HTML 26K 28: R19 Change Healthcare Joint Development Agreement HTML 34K 29: R20 Basis of Presentation and Summary of Significant HTML 83K Accounting Policies (Policies) 30: R21 Basis of Presentation and Summary of Significant HTML 55K Accounting Policies (Tables) 31: R22 Revenue (Tables) HTML 29K 32: R23 Acquisitions (Tables) HTML 109K 33: R24 Goodwill and Intangible Assets (Tables) HTML 58K 34: R25 Fair Value Measurements (Tables) HTML 74K 35: R26 Debt (Tables) HTML 26K 36: R27 Equity-based Compensation (Tables) HTML 116K 37: R28 Net Loss Per Share Attributable to Common HTML 101K Stockholders (Tables) 38: R29 Change Healthcare Joint Development Agreement HTML 29K (Tables) 39: R30 Basis of Presentation and Summary of Significant HTML 39K Accounting Policies - Basis of Presentation and Principles of Consolidation (Details) 40: R31 Basis of Presentation and Summary of Significant HTML 30K Accounting Policies - Capitalized Internal-Use Software Costs (Details) 41: R32 Basis of Presentation and Summary of Significant HTML 39K Accounting Policies - Concentration of Credit Risk (Details) 42: R33 Revenue - Revenue and Deferred Revenue (Details) HTML 38K 43: R34 Revenue - Revenue and Deferred Revenue Narratives HTML 25K (Details) 44: R35 Revenue - Cost to obtain and fulfill a contract HTML 39K (Details) 45: R36 Acquisitions - Summary of Purchase Consideration HTML 42K (Details) 46: R37 Acquisitions - Shares Issued (Details) HTML 207K 47: R38 Acquisitions - Summary of Estimated Fair Values of HTML 112K Assets Acquired and Liabilities Assumed (Details) 48: R39 Goodwill and Intangible Assets - Carrying amount HTML 25K of goodwill (Details) 49: R40 Goodwill and Intangible Assets - Intangible assets HTML 63K (Details) 50: R41 Fair Value Measurements (Details) HTML 39K 51: R42 Fair Value Measurements - Level 3 Contingent HTML 27K Consideration (Details) 52: R43 Debt - Notes (Details) HTML 29K 53: R44 Debt (Details) HTML 142K 54: R45 Equity-based Compensation - Compensation expense HTML 33K (Details) 55: R46 Equity-based Compensation - Stock Options HTML 70K (Details) 56: R47 Equity-based Compensation - Stock Option Activity HTML 85K (Details) 57: R48 Equity-based Compensation - Restricted Stock Units HTML 102K (Details) 58: R49 Equity-based Compensation - Employee Stock HTML 47K Purchase Plan (Details) 59: R50 Income Taxes (Details) HTML 34K 60: R51 Net income (Loss) Per Share Attributable to Common HTML 60K Stockholders (Details) 61: R52 Net income (Loss) Per Share Attributable to Common HTML 50K Stockholders - Stock Options (Details) 62: R53 Commitments and Contingencies - Legal Proceedings HTML 32K (Details) 63: R54 Change Healthcare Joint Development Agreement HTML 56K (Details) 66: XML IDEA XML File -- Filing Summary XML 123K 64: XML XBRL Instance -- accd-20211130x10q_htm XML 2.15M 65: EXCEL IDEA Workbook of Financial Reports XLSX 93K 6: EX-101.CAL XBRL Calculations -- accd-20211130_cal XML 170K 7: EX-101.DEF XBRL Definitions -- accd-20211130_def XML 660K 8: EX-101.LAB XBRL Labels -- accd-20211130_lab XML 1.42M 9: EX-101.PRE XBRL Presentations -- accd-20211130_pre XML 1.00M 5: EX-101.SCH XBRL Schema -- accd-20211130 XSD 180K 67: JSON XBRL Instance as JSON Data -- MetaLinks 353± 550K 68: ZIP XBRL Zipped Folder -- 0001558370-22-000200-xbrl Zip 341K
Download this zipped .zip folder | |
Files: | accd-20211130.xsd accd-20211130_cal.xml accd-20211130_def.xml accd-20211130_lab.xml accd-20211130_pre.xml accd-20211130x10q.htm accd-20211130xex31d1.htm accd-20211130xex31d2.htm accd-20211130xex32d1.htm |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/10/21 Accolade, Inc. 8-K:1,3,8,9 6/09/21 12:1.5M Toppan Merrill/FA 3/29/21 Accolade, Inc. 8-K:1,2,3,8 3/23/21 14:1.3M Toppan Merrill/FA 3/04/21 Accolade, Inc. 8-K:1,3,8,9 3/03/21 13:1.5M Toppan Merrill/FA 7/10/20 Accolade, Inc. 8-K:5,9 7/07/20 2:58K Toppan Merrill/FA 2/28/20 Accolade, Inc. S-1 39:24M Toppan Merrill-FA |